| Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP L Gil Gonzalez, KD Won, Z Tawhidi, E Cummins, Y Cruz-Leal, ... Blood Advances 8 (8), 1869-1879, 2024 | | 2024 |
| Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1 DV Chouljenko, YM Murad, IF Lee, Z Delwar, J Ding, G Liu, X Liu, X Bu, ... Molecular Therapy-Oncolytics 28, 334-348, 2023 | 5 | 2023 |
| Pre-existing HSV-1 immunity enhances anticancer efficacy of a novel immune-stimulating oncolytic virus J Ding, YM Murad, Y Sun, IF Lee, I Samudio, X Liu, WWG Jia, R Zhao Viruses 14 (11), 2327, 2022 | 12 | 2022 |
| Anti-podocalyxin antibodies and methods of using the same KM Mcnagny, CD Roskelley, MR Hughes, DC Hernaez, KO Blixt, ... US Patent App. 17/402,460, 2022 | | 2022 |
| Genetically modified enterovirus vectors H Luo, WWG Jia, H Liu, I Samudio US Patent App. 17/633,181, 2022 | | 2022 |
| Chelators and methods of making and using same LLL LI, C Orvig, F Benard, K Lin, JM Rousseau, I Samudio US Patent App. 17/441,125, 2022 | | 2022 |
| Targeting a tumor-specific epitope on podocalyxin increases survival in human tumor preclinical models D Canals Hernaez, MR Hughes, Y Li, I Mainero Rocca, P Dean, ... Frontiers in Oncology 12, 856424, 2022 | 7 | 2022 |
| Anti-podocalyxin antibodies and methods of using the same KM Mcnagny, CD Roskelley, MR Hughes, DC Hernaez, KO Blixt, ... US Patent 11,090,383, 2021 | 2 | 2021 |
| Pre-existing HSV-1 Immunity enhances anti-cancer efficacy of a novel immune stimulating oncolytic virus-VG161 J Ding, J Sun, Y Murad, E Lee, I Samudio, W Jia, R Zhao Cancer Research 81 (13_Supplement), 1913-1913, 2021 | | 2021 |
| Induction of durable antitumor response by a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes DV Chouljenko, J Ding, IF Lee, YM Murad, X Bu, G Liu, Z Delwar, Y Sun, ... Biomedicines 8 (11), 484, 2020 | 35 | 2020 |
| Catalytic Asymmetric Substitution Reaction of 3-Substituted 2-Indolylmethanols with 2-Naphthols JP Lan, YN Lu, KW Chen, F Jiang, F Gao, YC Zhang, F Shi Synthesis 52 (23), 3684-3692, 2020 | 8 | 2020 |
| First evidence of Podocalyxin as a new target for α-radioimmunotherapy of aggressive solid tumors J Rousseau, PHW Chan, H Merkens, L Li, P Bergqvist, N Colpo, C Uribe, ... Journal of Nuclear Medicine 61 (supplement 1), 1082-1082, 2020 | | 2020 |
| Oncolytic virotherapy in hepato‐bilio‐pancreatic cancer: the key to breaking the log jam? Y Li, Y Shen, R Zhao, I Samudio, W Jia, X Bai, T Liang Cancer Medicine 9 (9), 2943-2959, 2020 | 15 | 2020 |
| PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin DC Hernaez, MR Hughes, P Dean, P Bergqvist, I Samudio, O Blixt, ... Journal for ImmunoTherapy of Cancer 8 (2), 2020 | 18 | 2020 |
| Podocalyxin, a new target for radioimmunotherapy of pancreatic cancers J Rousseau, PHW Chan, H Merkens, K Gitschtaler, L Li, P Bergqvist, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 46 (SUPPL 1 …, 2019 | | 2019 |
| ANTI-PODOCALYXIN ANTIBODIES AND METHODS OF USE KM MCNAGNY, CD Roskelley, MR Hughes, DC HERNAEZ, KO BLIXT, ... | | 2019 |
| UV Light–inactivated HSV-1 Stimulates Natural Killer Cell–induced Killing of Prostate Cancer Cells I Samudio, E Hofs, B Cho, M Li, K Bolduc, L Bu, G Liu, V Lam, P Rennie, ... Journal of Immunotherapy 42 (5), 162-174, 2019 | 7 | 2019 |
| Recent advances in the synthesis of unsymmetrical bisindolylmethane derivatives A Palmieri, M Petrini Synthesis 51 (04), 829-841, 2019 | 43 | 2019 |
| An efficient and ecofriendly three-component reaction for the rapid synthesis of 2-Amino-4H-chromenes catalyzed by a DABCO-based ionic liquid CB Li, YW Li, DZ Xu Synthesis 50 (18), 3708-3714, 2018 | 20 | 2018 |
| Cell-surface proteomics for the identification of novel therapeutic targets in cancer L Kuhlmann, E Cummins, I Samudio, T Kislinger Expert review of proteomics 15 (3), 259-275, 2018 | 68 | 2018 |
